Back to Search
LEROY MELL, PHD
PHD
Clinical Laboratory Director (Non-physician)
NPI: 1144602533Individual
Specialties, Licenses & Credentials
Clinical Laboratory Director (Non-physician)Primary
Technician, Pathology — Clinical Laboratory Director, Non-physician
Code: 247ZC0005X
DI 31224(FL)
Research & Publications (20)
Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation.
PMID 18823018·Cancer·2008
8-other
Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
PMID 17996390·Int J Radiat Oncol Biol Phys·2008
4-observational
Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
PMID 18936351·Arch Otolaryngol Head Neck Surg·2008
8-other
Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical cancer.
PMID 18640499·Int J Radiat Oncol Biol Phys·2008
4-observational
Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine.
PMID 18798703·Expert Opin Drug Metab Toxicol·2008
4-observational
Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.
PMID 18037584·Int J Radiat Oncol Biol Phys·2008
6-review
Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience.
PMID 17925552·J Clin Oncol·2007
4-observational
Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: a meta-analysis.
PMID 17289291·Int J Radiat Oncol Biol Phys·2007
1-meta
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
PMID 16757127·Int J Radiat Oncol Biol Phys·2006
8-other
Intensity-modulated radiation therapy in gynecologic malignancies: current status and future directions.
PMID 16728946·Clin Adv Hematol Oncol·2006
6-review
A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial cancer patients.
PMID 16618581·Int J Radiat Oncol Biol Phys·2006
8-other
Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients.
PMID 15752887·Int J Radiat Oncol Biol Phys·2005
8-other
Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder.
PMID 15995031·Pediatrics·2005
8-other
Compliance with national immunization guidelines for children younger than 2 years, 1996-1999.
PMID 15687456·Pediatrics·2005
8-other
Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial cancer.
PMID 15328195·Clin Cancer Res·2004
8-other
A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy.
PMID 14643959·Radiother Oncol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1001 JUPITER PARK DR, SUITE 117
JUPITER, FL 33458 - Phone
- (631) 737-4168
Quick Facts
- NPI
- 1144602533
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile